AM

Ahmed Misbah Muddebihal

Active Director Director DIN 11485404
DIN 11485404 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ahmed Misbah Muddebihal

Data last updated:

Ahmed Misbah Muddebihal is a Director at Curiam Healthcare Solutions Private Limited (since 2026).

DIN 11485404
Primary Designation Director
First Appointment 15 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jan 20262026Active

Board colleagues of Ahmed Misbah Muddebihal

Directorship timeline

Open interactive timeline →
Curiam Healthcare Solutions Private Limited
Premium access

Shareholding and investment profile for Ahmed Misbah Muddebihal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ahmed Misbah Muddebihal

Ahmed Misbah Muddebihal currently holds 1 directorship: Curiam Healthcare Solutions Private Limited (Director, since 15 Jan 2026).

Ahmed Misbah Muddebihal was first appointed on 15 Jan 2026 as Director at Curiam Healthcare Solutions Private Limited.

The current boards of Ahmed Misbah Muddebihal's companies include Dadapeer Ballary (Curiam Healthcare Solutions Private Limited), Rajesh N Mylar (Curiam Healthcare Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available